Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jyothi, K. R. | - |
dc.contributor.author | Beloor, Jagadish | - |
dc.contributor.author | Jo, Ara | - |
dc.contributor.author | Minh Nam Nguyen | - |
dc.contributor.author | Choi, Tae Gyu | - |
dc.contributor.author | Kim, Jin-Hwan | - |
dc.contributor.author | Akter, Salima | - |
dc.contributor.author | Lee, Sang-Kyung | - |
dc.contributor.author | Maeng, Chi Hoon | - |
dc.contributor.author | Baik, Hyung Hwan | - |
dc.contributor.author | Kang, Insug | - |
dc.contributor.author | Ha, Joohun | - |
dc.contributor.author | Kim, Sung Soo | - |
dc.date.accessioned | 2022-07-16T00:56:28Z | - |
dc.date.available | 2022-07-16T00:56:28Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2015-01 | - |
dc.identifier.issn | 1176-9114 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/158115 | - |
dc.description.abstract | Therapeutic options for hepatitis C virus (HCV) infection have been limited by drug resistance and adverse side effects. Targeting the host factor cyclophilin A (CypA), which is essential for HCV replication, offers a promising strategy for antiviral therapy. However, due to its immunosuppressive activity and severe side effects, clinical application of cyclosporine A (CsA) has been limited as an antiviral agent. To overcome these drawbacks, we have successfully developed a liver-specific, sustained drug delivery system by conjugating the liver-targeting peptide (LTP) to PEGylated CsA-encapsulated poly (lactic-co-glycolic) acid (PLGA) nanoparticles. Furthermore, our delivery system exhibited high specificity to liver, thus contributing to the reduced immunosuppressive effect and toxicity profile of CsA. Finally, targeted nanoparticles were able to effectively inhibit viral replication in vitro and in an HCV mouse model. As a proof of principle, we herein show that our delivery system is able to negate the adverse effects of CsA and produce therapeutic effects in an HCV mouse model. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | DOVE MEDICAL PRESS LTD | - |
dc.title | Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Sang-Kyung | - |
dc.identifier.doi | 10.2147/IJN.S74723 | - |
dc.identifier.scopusid | 2-s2.0-84961289086 | - |
dc.identifier.wosid | 000348729600002 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF NANOMEDICINE, v.10, pp.903 - 921 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF NANOMEDICINE | - |
dc.citation.title | INTERNATIONAL JOURNAL OF NANOMEDICINE | - |
dc.citation.volume | 10 | - |
dc.citation.startPage | 903 | - |
dc.citation.endPage | 921 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | CYCLOPHILIN INHIBITORS | - |
dc.subject.keywordPlus | DELIVERY | - |
dc.subject.keywordPlus | NEPHROTOXICITY | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | THERAPIES | - |
dc.subject.keywordPlus | AGENTS | - |
dc.subject.keywordPlus | PEG | - |
dc.subject.keywordAuthor | HCV | - |
dc.subject.keywordAuthor | liver-targeting peptide | - |
dc.subject.keywordAuthor | targeted drug delivery | - |
dc.identifier.url | https://www.dovepress.com/liver-targeted-cyclosporine-a-encapsulated-poly-lactic-co-glycolic-aci-peer-reviewed-fulltext-article-IJN | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.